Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

The Present Scenario of Cervical Cancer Control and HPV Epidemiology in India: an Outline

Senapathy, J Giftson;Umadevi, P;Kannika, PS

  • Published : 20110500
⟨ Previous Next ⟩

Abstract

Objective: To give a clear picture with epidemiological evidence about the present scenario of cervical cancer control and HPV in India. Design: Review of published studies, concentrating on recent systematic reviews, meta-analyses and large prospective studies. Conclusions and recommendations: Cervical cancer is unique among cancers in that it can largely be prevented through screening and removal of precursor lesions. It is the second most common cancer among women worldwide and is the most common malignancy in developing countries, particularly in India. Nowadays, cervical screening for women is necessary because there are no signs and symptoms of cervical precancers. The establishment of a prevention program is urgently required considering both screening and vaccination. But most women in India do not have access to effective screening programmes. It has been estimated that in India, even with a major effort to expand cytology services, it will not be possible to screen even one-fourth of the population once in a lifetime in the near future. New HPV vaccines will also help prevent HPV infection and the precancerous changes that lead to cervical cancer. The focus on detection and prevention of cervical cancer must be emphasized in a highly populated country like India to prevent its extensive spread.

Keywords

References

  1. Aggarwal R, Gupta S, Nijhawan R, et al (2009). Prevalence of high-risk human papillomavirus infections in women with benign cervical cytology: A hospital based study from North India. Indian J of Cancer, 43, 110-116
  2. Alliance for Cervical Cancer Prevention (ACCP) (2004). Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. Seattle: ACCP.
  3. Arbyn M, Sasieni P, Meijer CJ, et al (2006). Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses. Vaccine, 24, 78-89. https://doi.org/10.1016/j.vaccine.2006.05.117
  4. Bang RA, Bang AT, Baitule M, et al (1989). High Prevalence of Gynaecological diseases in Rural Indian Women. Lancet, 1, 85-88
  5. Basu PS, Sankaranarayanan R, Mandal R, et al (2003). Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer, 13, 626-32. https://doi.org/10.1046/j.1525-1438.2003.13394.x
  6. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, et al (2001). Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 98, 441-44. https://doi.org/10.1016/S0029-7844(01)01454-5
  7. Bhatla N, Dar L, Patro AR, Kriplani A, Gulati A, et al (2006). Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol 25, 398-402. https://doi.org/10.1097/01.pgp.0000209574.62081.e4
  8. Cancer Atlas India. Available at: http://www.canceratlasindia.org/chapter6.asp (last accessed: April 2008).
  9. Cervical cancer: Fact sheet. National Institute of Health, September 2007.
  10. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-8. https://doi.org/10.1016/S0140-6736(05)67069-9
  11. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88, 63-73. https://doi.org/10.1038/sj.bjc.6600688
  12. Curado MP, Edwards B, Shin HR, et al (2007). Cancer Incidence in Five continents. IARC Scientific Publications No 160, Lyon: IARC Press, Lyon pp 90.
  13. Dabash R, Vajpayee J, Jacob M, et al (2005). A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reprod Health 2, 11.
  14. Denny L, Kuhn L, De Souza M, et al (2005). Screen and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA, 294, 2173-81. https://doi.org/10.1001/jama.294.17.2173
  15. Denny L, Kuhn L, Pollack A, Wainwright H, Wright T (2000). Evaluation of alternative methods of cervical cancer screening in resource poor settings. Cancer, 89, 823-26.
  16. Denny L, Kuhn L, Pollack A, Wright TC Jr (2002). Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer, 94, 1699-707. https://doi.org/10.1002/cncr.10381
  17. Dilip TR (2005). Extent of Inequity in Access to Health Care Services in India. In 'Review of Health Care in India', Eds Gangolli LV, Duggal R, Shukla A. Review of Health Care in India. Centre for Enquiry into Health and Allied Themes, pp. 247-268.
  18. Directorate General of Health Services (1984). National Cancer Control Program of India. Government of India, New Delhi.
  19. Duggal R, Gangolli LV (2005). Introduction to Review of Healthcare in India. In 'A Review of Healthcare in India', Eds Gangolli LV, Duggal R, Shukla. A Review of Healthcare in India. Centre for Enquiry into Health and Allied Themes, pp. 3-18.
  20. Ferenczy A, France E (2002). Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncology, 3, 11-16. https://doi.org/10.1016/S1470-2045(01)00617-9
  21. Ferlay J, Bray F, Pisani P and Parkin DM (2001). GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Version 1. 0. Lyon: IARC Press.
  22. Ferlay J, Bray F, Pisani P, Parkin DM (2004). GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon: IARC Press.
  23. Franceschi S, Rajkumar R, Snijders PJ, et al (2005). Papillomavirus infection in rural women in southern India. Br J Cancer, 92, 601-6. https://doi.org/10.1038/sj.bjc.6602348
  24. Franceschi S, Rajkumar T, Vaccarella S, et al (2003). Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer, 107, 127-33. https://doi.org/10.1002/ijc.11350
  25. Gajalakshmi V, Rajaraman S, Shanta V (2000). A survival study of cancer in Chennai, India. Indian J. Cancer; 37, 158-164.
  26. Gheit T, Vaccarella S, Schmitt M, et al.( 2009). Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine 27, 636-639. https://doi.org/10.1016/j.vaccine.2008.11.041
  27. Goldie S, Galkin L, Goldhaber-Fiebert J, et al (2005). Cost effectiveness of cervical screening in five developing countries. N Eng J Med, 353, 2158-2168. https://doi.org/10.1056/NEJMsa044278
  28. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC (2001). Policy analysis of cervical cancer screening strategies in lowresource settings: clinical benefits and cost-effectiveness. JAMA, 285, 3107-15. https://doi.org/10.1001/jama.285.24.3107
  29. IARC Handbooks on Cancer Prevention (2004). Cervix cancer screening. IARC Press, Lyon, 10.
  30. IARC Working Group (1995). Human Papillomaviruses. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Lyon: International Agency for Research on Cancer, 65.
  31. IARC working group: Summary (1986). In 'Screening for cancer of uterine cervix', Eds Hakama M. IARC scientific Publication No 76, Lyon, pp 133-42.
  32. International Institute for Population Sciences (IIPS). National Family Health Survey (NFHS-3), India. 2005-2006. Ministry of Health and Family Welfare, Government of India. Available at: http://www.nfhsindia.org/pdf/IN.pdf (last accessed: April 2008).
  33. Kim JJ, Ortendahl J, Goldie SJ (2009). Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States. Annals of Internal Medicine 151, 538-545. https://doi.org/10.7326/0003-4819-151-8-200910200-00007
  34. Juneja A, Murthy NS, Tuteja RK, Sardana S, Das DK (1997). Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening. Neoplasma 44, 272-4.
  35. Sarkar K, Bhattacharya S, Bhattacharyya S, Chatterjee S, Mallick AH, Chakraborti S, et al. (2008). Oncogenic human papilloma virus and cervical pre- cancerous lesions in brothel-based sex workers in India. Journal of Infection and Public Health 1, 121-128. https://doi.org/10.1016/j.jiph.2008.09.001
  36. Krishnan Nair M, Sankaranarayanan R (1991). Epidemiological lead to cancer control. Cancer causes Control 2, 263-265. https://doi.org/10.1007/BF00052143
  37. Laara E, Day NE, Hakama M (1987). trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes. Lancet I, 1247-1249
  38. Laikangbam P, Sengupta S, Bhattacharya P, et al (2007). A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India. Int J Gynecol Cancer 17,107-17. https://doi.org/10.1111/j.1525-1438.2007.00827.x
  39. Legood R, Gray AM, Mahe C, et al (2005). Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer, 117, 981-7. https://doi.org/10.1002/ijc.21220
  40. Londhe M, George SS, Seshadri L (1997). Detection of CIN by naked eye visualization after application of acetic acid. Indian J Cancer 34, 88-91.
  41. Mandal R, Mittal S, Basu P (2003). Management of cervical precancer. In 'Detection, diagnosis and management of cervical intraepithelial neoplasia'. Eds Lodha ND, Kamal MM. Nagpur, 1.
  42. Mandelblatt JS, Lawrence WF, Galkin L, et al (2002). Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst, 94, 1469-83. https://doi.org/10.1093/jnci/94.19.1469
  43. McInlay JB (1996). Some contributions from the social system to gender inequalities in heart disease. J Health Soc Behav, 37, 1-26. https://doi.org/10.2307/2137228
  44. Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N, et al (1998). The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Gynecol Oncol, 69, 205-9. https://doi.org/10.1006/gyno.1998.4991
  45. Murthy NS, Agarwal SS, Prabhakar AK, Sharma S, Das DK (1993). Estimation of reduction of life-time risk of cervical cancer through one life-time screening. Neoplasma, 40, 255-8.
  46. National Sample Survey, 42nd and 52nd Round. National Sample Survey Organisation, Government of India. New Delhi.
  47. Nene BM, Jayant K, Arrossi S, Shastri S, Budukh A, Hingmire S, et al (2007). Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ, 85, 264-72. https://doi.org/10.2471/BLT.06.031195
  48. Parashari A, Singh V, Sehgal A, Satyanarayana L, Sodhani P, Gupta MM (2000). Lowcost technology for screening uterine cervical cancer. Bull World Health Organ, 78, 964-7.
  49. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002). Cancer incidence in five continents. IARC Scientific Publication, 8, 155.
  50. Paskett ED, Wewers ME, Ruffin MT (2004). Educational Strategies for the Prevention of Cervical Cancer. In 'Cervical Cancer: From Etiology to Prevention', Eds Rohan TE, Shah KV. Kluwer Academic Publishers USA. 9, pp237-259.
  51. Peedicayil A, Abraham P, Sathish N, John S, Shah K, Sridharan G, et al (2006). Human papillomavirus genotypes associated with cervical neoplasia in India. Int J Gynecol Cancer, 16, 1591-5. https://doi.org/10.1111/j.1525-1438.2006.00631.x
  52. Priya R (2006). Towards 'Health Security' for Women and Children: Exploring Debates and Options. In 'Securing Health for All Dimensions and Challenges', Eds Prasad S, Sathyamala C. Institute for Human Development, New Delhi pp.328-352.
  53. Priyanka Golikeri (2009). A new vaccine for cervical cancer and some good hope. Available at: http://cancersupport.aarogya.com/index.php?option=com_content&task=view&id=333&Itemid=361. Accessed November 2009
  54. Qiao YL, Sellors JW, Eder PS, et al (2008). A new HPV-DNA test for cervical-cancer screening in developing regions: a cross sectional study of clinical accuracy in rural China. Lancet Oncol, 9, 929-36. https://doi.org/10.1016/S1470-2045(08)70210-9
  55. Rao DN, Ganesh B (1998). Estimate of cancer incidence in India in 1991. Indian J Cancer, 35, 10-8.
  56. Ratcliffe J (1983). Social justice and the demographic transition: lessons from India's Kerala State In 'Practicing Health for All' , Eds Morley D, Rohde J and Williams G. Oxford University Press, pp 64-82.
  57. Sangwa-Lugoma G, Mahmud S, Nasr SH, et al (2006). Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer , 119, 1389-95. https://doi.org/10.1002/ijc.21972
  58. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al (2004). Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer, 110, 907-13. https://doi.org/10.1002/ijc.20190
  59. Sankaranarayanan R, Budukh A and Rajkumar R (2001). Effective screening programs for cervical cancer in low- and middle-income developing countries. Bull World Health Organ, 79, 954-962.
  60. Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, et al (2004). Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer, 112, 341-7. https://doi.org/10.1002/ijc.20396
  61. Sankaranarayanan R, Esmi A, Jayaraman R, Cherian J, Parkin DM (2000). Leads to cancer control based on cancer patterns in a rural population in south India. Cancer Causes Contr, 11, 433-9. https://doi.org/10.1023/A:1008900425151
  62. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, et al (2007). Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet, 370, 398-406. https://doi.org/10.1016/S0140-6736(07)61195-7
  63. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S (2005). A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet, 89( 2):4-12. https://doi.org/10.1016/j.ijgo.2005.01.009
  64. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, et al (2005). A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer, 116, 617-23. https://doi.org/10.1002/ijc.21050
  65. Sankaranarayanan R, Rajkumar R, Arrossi S, Theresa R, Esmy PO, Mahe C, et al, (2003). Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detect Prev,27, 457-65. https://doi.org/10.1016/j.cdp.2003.09.006
  66. Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L, et al (2007). Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer, 96, 738-43. https://doi.org/10.1038/sj.bjc.6603633
  67. Sankaranarayanan R, Rajkumar R, Theresa R, et al (2004). Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer, 109, 461-67. https://doi.org/10.1002/ijc.11726
  68. Sankaranarayanan R, Shastri SS, Basu P, Mahe C, Mandal R, Amin G, et al (2004). The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev, 28, 345-51. https://doi.org/10.1016/j.cdp.2004.04.004
  69. Sankaranarayanan R, Thara S, Sharma A, Roy C, Shastri S, Mahe C, et al (2004) . Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen, 11, 77-84. https://doi.org/10.1258/096914104774061056
  70. Sankaranarayanan R, Wesley R, Thara S, et al (2003). Test characteristics of visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening. Int J Cancer, 106, 404-8. https://doi.org/10.1002/ijc.11245
  71. Sankaranarayanan R, Wesley R. A Practical manual on visual screening for cervical neoplasia (2003). IARC Technical Publication No. 41, Lyon: IARC Press.
  72. Schensul SL, Mekki-Berrada A, Nastasi BK, Singh R, Burleson JA, Bojko M (2006). Men's extramarital sex, marital relationships and sexual risk in urban poor communities in India. J Urban Health, 83, 614-24. https://doi.org/10.1007/s11524-006-9076-z
  73. Sellors J, Sankaranarayanan R (2003). Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual. Lyon: IARC Press.
  74. Sen Amartya (2005). Introduction. In 'The Delivery of Primary Health Services. A Study in West Bengal and Jharkhand.' The Pratichi Health Report Number 1. TLM Books with Pratichi (India) Trust.
  75. Shanta V, (2003). Perspectives in Cervical Cancer prevention in India. The International Network for Cancer Treatment and Research.
  76. Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, et al (2005). Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ, 83, 186-94.
  77. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, et al (2005). Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis, 5, 116. https://doi.org/10.1186/1471-2334-5-116
  78. Stjernsward J, Eddy D, Luthra UK and Stanley K (1987). Plotting a new course for cervical cancer in developing countries. World Hlth Frm, 8, 42-45
  79. University of Zimbabwe/JHPIEGO Cervical Cancer Project (1999): visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet, 353, 869-73. https://doi.org/10.1016/S0140-6736(98)07033-0
  80. Vallikad E, Krishnan S, Kumaraswamy (1998). Studies, Strategies and Concepts for Women's Health in Women's Hands: A Community Approach for the Control of Cancer Cervix in Karnataka, India. Kidwai Mem. Instit. Onco. Bangalore, India.
  81. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah IV, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189, 12-19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  82. Watkins K (1995). The Oxfam Poverty Report. Oxford, UK. The Pratichi Research Team. The Delivery of Primary Health Services. A Study in West Bengal and Jharkhand. The Pratichi Health Report. Number 1. 2005, TLM Books with Pratichi (India) Trust.
  83. World Bank India (2001): Raising the Sights - Better Health Systems for India's Poor. Report No. 22304.
  84. World Health Organisation (1986). Control of Cancer Cervix. Bull. WHO, 64,607-618.
  85. World Health Organization Vaccine Preventable Diseases Monitoring System. Available at: http://www.who. int/vaccines/globalsummary/immunization/countryprofileselect.cfm (last accessed: April 2008)
  86. World Health Organization (2006). Comprehensive cervical cancer control. A guide to essential practice. Geneva: WHO.
  87. World Health Organization. Reproductive health indicators database. Available at: http://www.who.int/reproductivehealth/global monitoring/RHRxmls/RHRmainpage.htm (last accessed: April 2008).